Interestingly, excessive availability of the tumor-derived oncometabolite D-2-hydroxyglutarate destabilizes HIF-1α and boosts OXPHOS in Treg cells, thereby promoting their accumulation in tumors [112]. This evidence concerns the gene HIF1A and neoplasm.